Project Name：Apixaban
Registration Classification：3+6
Formulations and specifications ：Tablets: 2.5mg
Indications：For the prevention of blood clots after hip or knee replacement surgery .
Original Research Company：Bristol-Myers Squibb
Progress ：Recently reported to the State Bureau
Category ：Antithrombotic drugs
